Evidence map›Paper›PMID 29472602›Full record

ArticleScientific reports2018

HPV-transformed cells exhibit altered HMGB1-TLR4/MyD88-SARM1 signaling axis.

Mirian Galliote Morale, Walason da Silva Abjaude, Aline Montenegro Silva, Luisa Lina Villa, Enrique Boccardo

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Mirian Galliote MoraleDepartment of Biochemistry, Institute of Chemistry, Universidade de São Paulo, São Paulo, Brazil.ORCID 0000-0002-2778-7697
Walason da Silva AbjaudeDepartment of Microbiology, Institute of Biomedical Sciences, Universidade de São Paulo, São Paulo, Brazil.
Aline Montenegro SilvaDepartment of Microbiology, Institute of Biomedical Sciences, Universidade de São Paulo, São Paulo, Brazil.
Luisa Lina VillaCentre of Translational Oncology, Instituto do Câncer do Estado de São Paulo (ICESP), São Paulo, Brazil.
Enrique BoccardoDepartment of Microbiology, Institute of Biomedical Sciences, Universidade de São Paulo, São Paulo, Brazil. eboccardo@usp.br.
Universidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical cancer is one of the leading causes of cancer death in women worldwide. Persistent infection with high-risk human papillomavirus (HPV) types is the main risk factor for the development of cervical cancer precursor lesions. HPV persistence and tumor development is usually characterized by innate immune system evasion. Alterations in Toll-like receptors (TLR) expression and activation may be important for the control of HPV infections and could play a role in the progression of lesions and tumors. In the present study, we analyzed the mRNA expression of 84 genes involved in TLR signaling pathways. We observed that 80% of the differentially expressed genes were downregulated in cervical cancer cell lines relative to normal keratinocytes. Major alterations were detected in genes coding for several proteins of the TLR signaling axis, including TLR adaptor molecules and genes associated with MAPK pathway, NFκB activation and antiviral immune response. In particular, we observed major alterations in the HMGB1-TLR4 signaling axis. Functional analysis also showed that HMGB1 expression is important for the proliferative and tumorigenic potential of cervical cancer cell lines. Taken together, these data indicate that alterations in TLR signaling pathways may play a role in the oncogenic potential of cells expressing HPV oncogenes.

Indexed as

Armadillo Domain ProteinsCell Transformation, NeoplasticCytoskeletal ProteinsFemaleGene Expression Regulation, NeoplasticHEK293 CellsHeLa CellsHMGB1 ProteinHuman papillomavirus 16HumansMyeloid Differentiation Factor 88NF-kappa BPapillomavirus InfectionsSignal TransductionToll-Like Receptor 4Uterine Cervical NeoplasmsArmadillo Domain ProteinsCytoskeletal ProteinsHMGB1 ProteinMYD88 protein, humanMyeloid Differentiation Factor 88NF-kappa BSARM1 protein, humanTLR4 protein, humanToll-Like Receptor 4

Identifiers

PMID29472602
PMCPMC5823898
OpenAlexW2803142374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.